USPH Net Debt from 2010 to 2024

USPH Stock

USD 97.83 0.89 0.92%

US Physicalrapy's Net Debt is increasing with slightly volatile movements from year to year. Net Debt is estimated to finish at about 111.1 M this year. Net Debt is the total debt of US Physicalrapy minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

1991-12-31

Previous Quarter

146.1 M

Current Value

137.4 M

Quarterly Volatility

58.2 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check US Physicalrapy financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among US Physicalrapy's main balance sheet or income statement drivers, such as Interest Expense of 9.8 M, Total Revenue of 635 M or Gross Profit of 117.6 M, as well as many indicators such as Price To Sales Ratio of 2.99, Dividend Yield of 0.0194 or PTB Ratio of 4.71. USPH financial statements analysis is a perfect complement when working with US Physicalrapy Valuation or Volatility modules.

Check out the analysis of US Physicalrapy Correlation against competitors.

For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

Latest US Physicalrapy's Net Debt Growth Pattern

Below is the plot of the Net Debt of US Physicalrapy over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. US Physicalrapy's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in US Physicalrapy's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

USPH Net Debt Regression Statistics

	Arithmetic Mean	70,430,607
	Coefficient Of Variation	108.05
	Mean Deviation	59,312,061
	Median	33,332,000
	Standard Deviation	76,101,995
	Sample Variance	5791.5T
	Range	265.6M
	R-Value	0.76
	Mean Square Error	2662.3T
	R-Squared	0.57
	Significance	0
	Slope	12,882,974
	Total Sum of Squares	81081.2T

USPH Net Debt History

	2024	111.1 M
	2023	105.8 M
	2022	263.7 M
	2021	194.5 M
	2020	78.1 M
	2019	114.3 M
	2018	16.5 M

Other Fundumenentals of US Physicalrapy

Net Debt To E B I T D A

US Physicalrapy Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Good Will	Common Stock	Long Term Debt	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Short Term Investments	Net Tangible Assets	Total Permanent Equity	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Accumulated Depreciation	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	0.77	0.91	0.78	0.54	0.98	0.91	0.93	0.99	-0.41	0.56	0.88	-0.34	0.91	0.06	0.07	-0.83	0.77	0.88	0.85	0.65	-0.89	0.82	0.83	0.51	0.77
Total Stockholder Equity	0.98		0.63	0.89	0.67	0.51	0.92	0.97	0.88	0.95	-0.46	0.61	0.82	-0.38	0.87	0.07	-0.02	-0.78	0.73	0.85	0.78	0.58	-0.82	0.82	0.8	0.63	0.85
Net Debt	0.77	0.63		0.74	0.92	0.49	0.87	0.48	0.81	0.81	-0.26	0.36	0.84	-0.24	0.77	0.11	0.15	-0.8	0.55	0.74	0.75	0.56	-0.81	0.57	0.72	0.02	0.32
Retained Earnings	0.91	0.89	0.74		0.75	0.76	0.87	0.75	0.79	0.89	-0.7	0.8	0.74	-0.66	0.72	0.32	-0.25	-0.67	0.75	0.71	0.83	0.66	-0.91	0.65	0.64	0.24	0.52
Accounts Payable	0.78	0.67	0.92	0.75		0.49	0.86	0.56	0.75	0.82	-0.38	0.46	0.9	-0.35	0.85	0.16	-0.01	-0.87	0.51	0.84	0.68	0.48	-0.76	0.52	0.75	0.18	0.39
Net Receivables	0.54	0.51	0.49	0.76	0.49		0.48	0.35	0.32	0.53	-0.74	0.83	0.41	-0.73	0.27	0.72	-0.43	-0.27	0.63	0.34	0.72	0.7	-0.68	0.26	0.34	-0.08	0.09
Total Liab	0.98	0.92	0.87	0.87	0.86	0.48		0.84	0.96	0.98	-0.34	0.48	0.93	-0.27	0.94	0.04	0.13	-0.9	0.7	0.91	0.83	0.6	-0.87	0.81	0.87	0.44	0.71
Total Current Assets	0.91	0.97	0.48	0.75	0.56	0.35	0.84		0.81	0.88	-0.36	0.51	0.78	-0.27	0.86	-0.03	0.0	-0.75	0.63	0.84	0.65	0.45	-0.66	0.82	0.79	0.8	0.95
Short Term Debt	0.93	0.88	0.81	0.79	0.75	0.32	0.96	0.81		0.92	-0.21	0.36	0.82	-0.15	0.9	-0.05	0.25	-0.83	0.62	0.81	0.79	0.56	-0.82	0.82	0.85	0.41	0.73
Intangible Assets	0.99	0.95	0.81	0.89	0.82	0.53	0.98	0.88	0.92		-0.36	0.51	0.92	-0.3	0.92	0.05	0.1	-0.88	0.74	0.91	0.85	0.65	-0.9	0.83	0.85	0.49	0.73
Good Will	-0.41	-0.46	-0.26	-0.7	-0.38	-0.74	-0.34	-0.36	-0.21	-0.36		-0.97	-0.3	0.99	-0.21	-0.63	0.83	0.2	-0.37	-0.24	-0.33	-0.25	0.39	-0.19	-0.16	-0.05	-0.13
Common Stock	0.56	0.61	0.36	0.8	0.46	0.83	0.48	0.51	0.36	0.51	-0.97		0.42	-0.94	0.35	0.69	-0.73	-0.33	0.49	0.38	0.51	0.4	-0.52	0.33	0.35	0.16	0.29
Long Term Debt	0.88	0.82	0.84	0.74	0.9	0.41	0.93	0.78	0.82	0.92	-0.3	0.42		-0.24	0.95	0.02	0.05	-0.97	0.58	0.96	0.68	0.48	-0.74	0.76	0.87	0.51	0.67
Treasury Stock	-0.34	-0.38	-0.24	-0.66	-0.35	-0.73	-0.27	-0.27	-0.15	-0.3	0.99	-0.94	-0.24		-0.13	-0.63	0.85	0.13	-0.33	-0.17	-0.28	-0.21	0.36	-0.11	-0.07	0.05	-0.02
Property Plant Equipment	0.91	0.87	0.77	0.72	0.85	0.27	0.94	0.86	0.9	0.92	-0.21	0.35	0.95	-0.13		-0.08	0.17	-0.97	0.55	0.96	0.68	0.44	-0.71	0.77	0.91	0.61	0.8
Current Deferred Revenue	0.06	0.07	0.11	0.32	0.16	0.72	0.04	-0.03	-0.05	0.05	-0.63	0.69	0.02	-0.63	-0.08		-0.59	0.02	0.13	-0.05	0.34	0.32	-0.13	-0.08	0.17	-0.24	-0.14
Short Term Investments	0.07	-0.02	0.15	-0.25	-0.01	-0.43	0.13	0.0	0.25	0.1	0.83	-0.73	0.05	0.85	0.17	-0.59		-0.11	0.03	0.09	0.16	0.17	-0.11	0.13	0.19	0.05	0.15
Net Tangible Assets	-0.83	-0.78	-0.8	-0.67	-0.87	-0.27	-0.9	-0.75	-0.83	-0.88	0.2	-0.33	-0.97	0.13	-0.97	0.02	-0.11		-0.51	-0.95	-0.64	-0.39	0.67	-0.72	-0.9	-0.52	-0.7
Total Permanent Equity	0.77	0.73	0.55	0.75	0.51	0.63	0.7	0.63	0.62	0.74	-0.37	0.49	0.58	-0.33	0.55	0.13	0.03	-0.51		0.57	0.8	0.77	-0.78	0.57	0.49	0.24	0.45
Long Term Debt Total	0.88	0.85	0.74	0.71	0.84	0.34	0.91	0.84	0.81	0.91	-0.24	0.38	0.96	-0.17	0.96	-0.05	0.09	-0.95	0.57		0.65	0.42	-0.71	0.71	0.86	0.63	0.77
Capital Surpluse	0.85	0.78	0.75	0.83	0.68	0.72	0.83	0.65	0.79	0.85	-0.33	0.51	0.68	-0.28	0.68	0.34	0.16	-0.64	0.8	0.65		0.87	-0.92	0.63	0.74	0.15	0.49
Deferred Long Term Liab	0.65	0.58	0.56	0.66	0.48	0.7	0.6	0.45	0.56	0.65	-0.25	0.4	0.48	-0.21	0.44	0.32	0.17	-0.39	0.77	0.42	0.87		-0.75	0.47	0.51	0.03	0.3
Accumulated Depreciation	-0.89	-0.82	-0.81	-0.91	-0.76	-0.68	-0.87	-0.66	-0.82	-0.9	0.39	-0.52	-0.74	0.36	-0.71	-0.13	-0.11	0.67	-0.78	-0.71	-0.92	-0.75		-0.63	-0.63	-0.13	-0.44
Short Long Term Debt	0.82	0.82	0.57	0.65	0.52	0.26	0.81	0.82	0.82	0.83	-0.19	0.33	0.76	-0.11	0.77	-0.08	0.13	-0.72	0.57	0.71	0.63	0.47	-0.63		0.77	0.58	0.77
Net Invested Capital	0.83	0.8	0.72	0.64	0.75	0.34	0.87	0.79	0.85	0.85	-0.16	0.35	0.87	-0.07	0.91	0.17	0.19	-0.9	0.49	0.86	0.74	0.51	-0.63	0.77		0.57	0.79
Net Working Capital	0.51	0.63	0.02	0.24	0.18	-0.08	0.44	0.8	0.41	0.49	-0.05	0.16	0.51	0.05	0.61	-0.24	0.05	-0.52	0.24	0.63	0.15	0.03	-0.13	0.58	0.57		0.9
Capital Stock	0.77	0.85	0.32	0.52	0.39	0.09	0.71	0.95	0.73	0.73	-0.13	0.29	0.67	-0.02	0.8	-0.14	0.15	-0.7	0.45	0.77	0.49	0.3	-0.44	0.77	0.79	0.9

Click cells to compare fundamentals

About US Physicalrapy Financial Statements

Investors use fundamental indicators, such as US Physicalrapy's Net Debt, to determine how well the company is positioned to perform in the future. Although US Physicalrapy's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.

	Last Reported	Projected for Next Year
Net Debt	105.8 M	111.1 M
Net Debt To EBITDA	1.42	1.49

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:

How To Invest In USPH

Details

Is USPH Stock a good investment?

Details

What is US Physicalrapy's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of US Physicalrapy Correlation against competitors.

For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.24)

Dividend Share

1.75

Earnings Share

0.88

Revenue Per Share

42.489

Quarterly Revenue Growth

0.12

The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

USPH Net Debt from 2010 to 2024

Latest US Physicalrapy's Net Debt Growth Pattern

USPH Net Debt Regression Statistics

USPH Net Debt History

Other Fundumenentals of US Physicalrapy

US Physicalrapy Net Debt component correlations

About US Physicalrapy Financial Statements

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY